Showing results (291-300 of 687) with videos related to
Sort By:
Pageof 69
Current Pharmaceutical Design|April 10, 2009
The role of statins for the primary and secondary prevention of coronary heart disease in womenKonstantinos Tziomalos, Anna I Kakafika, Vasilios G Athyros, et al.The Cochrane Database of Systematic Reviews|November 1, 2014
Cilostazol for intermittent claudicationRachel Bedenis, Marlene Stewart, Marcus Cleanthis, et al.The Open Cardiovascular Medicine Journal|December 17, 2010
Involvement of signaling molecules on na/h exchanger-1 activity in human monocytesMaria Sarigianni, Apostolos Tsapas, Dimitri P Mikhailidis, et al.Expert Opinion on Pharmacotherapy|February 3, 2011
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?Manfredi Rizzo, Egle Corrado, Angelo Maria Patti, et al.Current Vascular Pharmacology|February 15, 2011
Definition of postprandial lipaemiaGenovefa D Kolovou, Dimitri P Mikhailidis, Børge G Nordestgaard, et al.Annals of Vascular Surgery|July 15, 2006
Statins and peripheral arterial disease: potential mechanisms and clinical benefitsMohamad E Alnaeb, Nasser Alobaid, Alexander M Seifalian, et al.The Open Cardiovascular Medicine Journal|June 11, 2011
Rectus sheath hematoma: a simplified emergency surgical approachMichael Mantelas, Niki Katsiki, Polychronis Antonitsis, et al.BMC Medicine|January 16, 2016
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debateF D Richard Hobbs, Maciej Banach, Dimitri P Mikhailidis, et al.Journal of Cardiac Surgery|March 10, 2009
Arteriovenous fistula leading to severe tortuosity and aneurysm formationMurat Ugurlucan, Ufuk Alpagut, Maciej Banach, et al.Nature Reviews. Nephrology|February 24, 2010
The role of Toll-like receptors in renal diseasesAnna Gluba, Maciej Banach, Simon Hannam, et al.Pageof 69